High-Resolution Melting Analysis for accurate detection of BRAF mutations: A systematic review and meta-analysis

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Dong ^a   Wang, Yan Yan ^b   Chuai, Zheng Ran ^a   Huang, Jun Fu ^a   Wang, Yun Xia ^a   Liu, Kai ^a   Zhang, Li Qun ^a   Yang, Zhao ^a   Shi, Da Chuan ^a   Liu, Qian ^a   Huang, Qing ^a   Fu, Wei Ling ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN;

ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN; META ANALYSIS; MUTATION; RECEIVER OPERATING CHARACTERISTIC; TRANSITION TEMPERATURE;

HUMANS; MUTATION; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS B-RAF; ROC CURVE; TRANSITION TEMPERATURE;

EID: 84894707500     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04168     Document Type: Article

References (42)

1. Pao, W. & Girard, N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 12, 175-180 (2011).
2. Yaeger, R. & Saltz, L. BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy. J Natl Compr Canc Netw. 10, 1456-1458 (2012).
3. Sclafani, F., Gullo, G., Sheahan, K. & Crown, J. BRAF mutations inmelanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications. Crit Rev Oncol Hematol. 87, 55-68 (2013).
4. Tol, J., Nagtegaal, I. D. & Punt, C. J. BRAF mutation in metastatic colorectal cancer. N Engl J Med. 361, 98-99 (2009).
5. Kumar, R. et al. BRAF mutations in metastatic melanoma: a possible association with clinical outcome. Clin Cancer Res. 9, 3362-3368 (2003). (Pubitemid 37082731)
6. Cohen, Y. et al. BRAF mutation in papillary thyroid carcinoma. JNatl Cancer Inst. 95, 625-627 (2003). (Pubitemid 36553510)
7. Ziai, J. &Hui, P. BRAF mutation testing in clinical practice. Expert RevMol Diagn. 12, 127-138 (2012).
8. Walther, Z., Ronski, K.,Wan, M. & Sklar, J. A TaqMan array system for mutation profiling of solid tumors using routine surgical pathology and cytology specimens. J Mol Diagn. 14, 704 (2012).
9. Tan, Y. H. et al. Detection of BRAF V600E mutation by pyrosequencing. Pathology. 40, 295-298 (2008). (Pubitemid 351563933)
10. Adeniran, A. J. et al. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid. 21, 717-723 (2011).
11. Wooster, R., Futreal, A. P. & Stratton, M. R. Sequencing Analysis of BRAF Mutations in Human Cancers. Methods Enzymol. 407, 218-224 (2006).
12. Szankasi, P. et al. A Quantitative Allele-Specific PCR Test for the BRAF V600E Mutation Using a Single Heterozygous Control Plasmid for Quantitation: A Model for qPCR Testing without Standard Curves. J Mol Diagn. 15, 248-254 (2013).
13. Pichler, M. et al. Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors. JMol Diagn. 11, 140-147 (2009).
14. Simi, L. et al.High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. Am J Clin Pathol. 130, 247-253 (2008).
15. Willmore-Payne, C., Holden, J. A., Tripp, S. & Layfield, L. J. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis. Hum Pathol. 36, 486-493 (2005). (Pubitemid 40776001)
16. Seth, R. et al. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Gut. 58, 1234-1241 (2009).
17. Bennani, B. et al.Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer. Int J Biol Markers. 25, 179-184 (2010).
18. Borras, E. et al. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing. BMC cancer. 11, (2011).
19. Bozzao, C. et al. Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients. Int J Biol Markers. 27, e366-374 (2012).
20. Hsieh, L.-L. et al. Characteristics and prevalence of KRAS, BRAF, and PIK3CA mutations in colorectal cancer by high-resolution melting analysis in Taiwanese population. Clin Chim Acta. 413, 1605-1611 (2012).
21. Krol, L. C. et al. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma. Eur J Cancer. 48, 1108-1115 (2012).
22. Mancini, I. et al. A High-Resolution Melting Protocol for Rapid and Accurate Differential Diagnosis of Thyroid Nodules. J Mol Diagn. 14, 501-509 (2012).
23. Ney, J. T., Froehner, S., Roesler, A., Buettner, R. & Merkelbach-Bruse, S. High-Resolution Melting Analysis as a Sensitive Prescreening Diagnostic Tool toDetect KRAS, BRAF, PIK3CA, and AKT1 Mutations in Formalin-Fixed, Paraffin-Embedded Tissues. Arch Pathol Lab Med. 136, 983-992 (2012).
24. Yang, L. et al. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma. Hum Pathol. 43, 1463-1470 (2012).
25. Guedes, J. G. et al. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer. BMC cancer. 13, (2013).
26. Richter, A. et al. A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma. Sci Rep. 3, 1659; DOI:10.1038/srep01659 (2013).
27. Xu, H.-B., Jiang, R.-H., Sha, W., Li, L. & Xiao, H.-P. PCR-Single-Strand Conformational Polymorphism Method for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis: Systematic Review and Meta-Analysis. J Clin Microbiol. 48, 3635-3640 (2010).
28. Boursault, L. et al. Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing. PLoS One. 8, e70826 (2013).
29. van Eijk, R. et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS One. 6, e17791 (2011).
30. Libra, M. et al. Analysis of BRAF Mutation in Primary andMetastatic Melanoma. Cell Cycle. 4, 1382-1384 (2005). (Pubitemid 41437127)
31. Wittwer, C., Reed, G., Gundry, C., Vandersteen, J. & Pryor, R. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem. 49, 853-860 (2003). (Pubitemid 36623462)
32. Taylor, C. F. Mutation scanning using high-resolution melting. Biochem Soc Trans. 37, 433-437 (2009).
33. Krypuy, M., Newnham, G. M., Thomas, D. M., Conron, M. & Dobrovic, A. High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC cancer. 6, 295 (2006).
34. Bastien, R. et al. High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling. Hum Mutat. 29, 757-764 (2008). (Pubitemid 351614601)
35. Vossen, R. H. A. M., Aten, E., Roos, A. & den Dunnen, J. T. High-Resolution Melting Analysis (HRMA) - More than just sequence variant screening. Hum Mutat. 30, 860-866 (2009).
36. Montgomery, J. L., Sanford, L. N. &Wittwer, C. T. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn. 10, 219-240 (2010).
37. Li, B. S. et al. Is high resolution melting analysis (HRMA) accurate for detection of human disease-associated mutations? A meta analysis. PLoS one. 6, e28078 (2011).
38. Takano, T. et al. Epidermal Growth Factor Receptor Mutation Detection Using High-Resolution Melting Analysis Predicts Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Gefitinib. Clin Cancer Res. 13, 5385-5390 (2007). (Pubitemid 47510364)
39. Wittwer, C. T. High-resolution DNA melting analysis: advancements and limitations. Hum Mutat. 30, 857-859 (2009).
40. Tindall, E. A., Petersen, D. C., Woodbridge, P., Schipany, K. & Hayes, V. M. Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments. Hum Mutat. 30, 876-883 (2009).
41. Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M. & Kleijnen, J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 3, 25 (2003).
42. Deville, W. L. et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol. 2, 9 (2002).